Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-19-014911
Filing Date
2019-10-02
Accepted
2019-10-02 18:08:22
Documents
2
Period of Report
2016-07-26

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 16766
2 ex24.htm EX-24 10335
  Complete submission text file 0001493152-19-014911.txt   28474
Mailing Address STERN AEGIS VENTURES 810 7TH AVENUE 22ND FLOOR NEW YORK NY 10019
Business Address
STERN ADAM K (Reporting) CIK: 0001403497 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38022 | Film No.: 191133590

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

EIN.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations